Articles

Long-form pieces on what the published BPC-157 record actually contains. Every article closes with the primary sources it draws on.

• An FDA panel voted 8-6 to recommend BPC-157. Almost nothing changed that day.

  2026-09-20

  In July 2026 an FDA advisory committee voted 8-6, with one abstention, to recommend BPC-157 for the 503A Bulks List. Headlines read like a decision had been made. Four things complicate that: the vote binds nobody, FDA's own staff had proposed the opposite, placement needs rulemaking that takes months, and FDA has still published no record of the vote at all.

• Everyone is talking about BPC-157. Almost no one has measured it in a person.

  2026-09-16

  FDA looked for data on what happens to BPC-157 inside the human body and found none by any route people actually use. In the two studies that did look, the authors couldn't find it in people's blood. A plain-language look at the gap between the buzz and the record.